This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Anesthesia
and you are
over 18
years old
4
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

The objective of this study is to evaluate the influence of different propofol formulations (plain or with remifentanil) on anesthetic induction. Propofol plain or with remifentanil is administered using a closed-loop algorithm in order to reach a Bispectral Index target of 50.

Provided treatments

  • Drug: Propofol (Astra-Zeneca), NaCl 0.9%
  • Drug: propofol 1% (Astra-Zeneca) and remifentanil
  • Drug: propofol 1% (Astra-Zeneca) and remifentanil
  • Drug: Propofol (Astra-Zeneca), NaCl 0.9%
  • Drug: Propofol (Astra-Zeneca) and remifentanil
  • Drug: Propofol (Astra-Zeneca) and remifentanil
  • Drug: Propofol (B-Braun) and NaCl 0.9%
  • Drug: Propofol (B-Braun) and remifentanil
  • Drug: Propofol (B-Braun) and remifentanil

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01592162. The sponsor of the trial is Hopital Foch and it is looking for 409 volunteers for the current phase.
Official trial title:
Dose-effect of Propofol for Anesthetic Induction: Double-blind Comparison of Different Propofol Formulations Administered Alone or With Remifentanil